The Scale Is Measuring The Wrong Thing
If you are on semaglutide or tirzepatide — or thinking about starting — let me be clear up front: these drugs work. I prescribe them. The results in the trials are better than anything we had before, and for a lot of people they are genuinely life-changing. This is not a warning against them. It is about what happens alongside them.
Weight loss is never one thing. Every pound that comes off is some mix of fat mass and lean mass — muscle, plus the bone and connective tissue that travel with it. The bathroom scale cannot tell those apart. Neither can BMI. Both will congratulate you either way.
In the STEP 1 body-composition substudy of semaglutide, roughly 39% of the total weight lost was lean mass. The tirzepatide substudy in SURMOUNT-1 came in lower, closer to 25%, but the pattern holds. A quarter to nearly 40% of what leaves is not fat. This is not unique to GLP-1s — rapid loss from any cause does it, including bariatric surgery and aggressive dieting. What is new is how many people are now doing it at once.
Here is why it matters more than it sounds. Muscle mass and strength are among the better predictors of all-cause mortality we have, and skeletal muscle is where the large majority of the glucose you eat is disposed of. Lose enough of it and you arrive at a lower weight with a worse metabolic setup than you started with — and considerably less margin at 75. The goal was never to weigh less. It was to be composed differently.
The Drug Is Identical. The Protocol Isn't.
Unsupervised
Weight Loss
The dose escalates on schedule. Appetite drops hard and total intake falls with it — protein included. Training doesn't change, because nobody mentioned it. The scale moves fast and everyone is delighted. On a DEXA scan, a quarter to a third of that loss is lean tissue.
Practical read: you get smaller, not necessarily healthier.
Managed
Fat Loss
Same medication, same dose. A protein floor is set and defended, resistance training is non-negotiable, titration slows if intake collapses, and body composition is measured rather than assumed.
Practical read: the loss comes out of fat, where you wanted it from.
Protein Gets Harder, Not Easier
These medications suppress appetite indiscriminately, and protein is the most satiating macronutrient — so it is usually the first thing people quietly stop eating. Roughly 1.6 g per kg of body weight per day is the working target, and most patients cannot hit it on a suppressed appetite without planning it deliberately. Shakes absolutely count.
Lifting Is the Non-Negotiable
Resistance training is the signal that tells your body to hold on to muscle while it is in a caloric deficit. Without that signal, muscle is simply available fuel. Two to three sessions a week, whole body, progressively loaded. Cardio is good for you and it will not do this particular job.
Three Things Worth Doing This Week
-
Get a baseline DEXA scan
If you are already several months in, today is still the earliest you can start. The scan takes about ten minutes and turns “I lost 22 pounds” into “I lost 18 pounds of fat and four pounds of muscle” — which is an entirely different conversation, with different next steps.
-
Count your protein honestly for three days
Not an estimate. Log it. Most people on a GLP-1 are eating dramatically less than they believe, because appetite suppression makes a large deficit feel like nothing at all. Three recorded days is usually enough to expose the gap.
-
Start lifting before you think you need to
Two full-body sessions a week is enough to change the trajectory of this. If you wait until the weight is off to begin, you are rebuilding lost tissue rather than protecting tissue you still have — and rebuilding is much slower.
Weight Loss Got Easy. Doing It Well Didn't.
Whether you are on a GLP-1 now, considering one, or coming off one and wondering what happens next, thirty minutes is a good investment. We'll talk through what to measure and how to protect what matters.